SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001062993-24-010535
Filing Date
2024-05-17
Accepted
2024-05-16 19:19:02
Documents
13
Period of Report
2024-03-22

Document Format Files

Seq Description Document Type Size
1 FORM 6-K form6k.htm 6-K 7482
2 EXHIBIT 99.1 exhibit99-1.htm EX-99.1 8397
3 EXHIBIT 99.2 exhibit99-2.htm EX-99.2 7960
4 EXHIBIT 99.3 exhibit99-3.htm EX-99.3 228081
5 EXHIBIT 99.4 exhibit99-4.htm EX-99.4 820
6 EXHIBIT 99.5 exhibit99-5.htm EX-99.5 546
7 EXHIBIT 99.6 exhibit99-6.htm EX-99.6 4826
8 GRAPHIC exhibit99-1x1x1.jpg GRAPHIC 2508
9 GRAPHIC exhibit99-3x001.jpg GRAPHIC 33597
10 GRAPHIC exhibit99-4xu003.jpg GRAPHIC 178857
11 GRAPHIC exhibit99-4xu004.jpg GRAPHIC 127329
12 GRAPHIC exhibit99-5xu002.jpg GRAPHIC 127329
13 GRAPHIC exhibit99-6x001.jpg GRAPHIC 3341
  Complete submission text file 0001062993-24-010535.txt   911318
Mailing Address 19 VESTRY STREET NEW YORK NY 10013
Business Address 19 VESTRY STREET NEW YORK NY 10013 6474072515
BRIGHT MINDS BIOSCIENCES INC. (Filer) CIK: 0001827401 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0930
Type: 6-K | Act: 34 | File No.: 001-40997 | Film No.: 24957324
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)